These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22364389)

  • 21. Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models.
    Upadhyay M; Agarwal S; Bhadauriya P; Ganesh S
    Neurobiol Dis; 2017 Apr; 100():39-51. PubMed ID: 28063983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, purification and characterization of soluble red rooster laforin as a fusion protein in Escherichia coli.
    Brewer MK; Husodo S; Dukhande VV; Johnson MB; Gentry MS
    BMC Biochem; 2014 Apr; 15():8. PubMed ID: 24690255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease.
    Rai A; Mishra R; Ganesh S
    Hum Mol Genet; 2017 Dec; 26(24):4778-4785. PubMed ID: 28973665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
    Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
    Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
    Puri R; Ganesh S
    Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase.
    Romá-Mateo C; Solaz-Fuster Mdel C; Gimeno-Alcañiz JV; Dukhande VV; Donderis J; Worby CA; Marina A; Criado O; Koller A; Rodriguez De Cordoba S; Gentry MS; Sanz P
    Biochem J; 2011 Oct; 439(2):265-75. PubMed ID: 21728993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy.
    Mitra S; Chen B; Wang P; Chown EE; Dear M; Guisso DR; Mariam U; Wu J; Gumusgoz E; Minassian BA
    Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36511140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system.
    Garyali P; Siwach P; Singh PK; Puri R; Mittal S; Sengupta S; Parihar R; Ganesh S
    Hum Mol Genet; 2009 Feb; 18(4):688-700. PubMed ID: 19036738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin conjugating enzyme E2-N and sequestosome-1 (p62) are components of the ubiquitination process mediated by the malin-laforin E3-ubiquitin ligase complex.
    Sánchez-Martín P; Romá-Mateo C; Viana R; Sanz P
    Int J Biochem Cell Biol; 2015 Dec; 69():204-14. PubMed ID: 26546463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).
    Worby CA; Gentry MS; Dixon JE
    J Biol Chem; 2008 Feb; 283(7):4069-76. PubMed ID: 18070875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.
    Gentry MS; Worby CA; Dixon JE
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8501-6. PubMed ID: 15930137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interdependence of laforin and malin proteins for their stability and functions could underlie the molecular basis of locus heterogeneity in Lafora disease.
    Mittal S; Upadhyay M; Singh PK; Parihar R; Ganesh S
    J Biosci; 2015 Dec; 40(5):863-71. PubMed ID: 26648032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lafora disease: Current biology and therapeutic approaches.
    Mitra S; Gumusgoz E; Minassian BA
    Rev Neurol (Paris); 2022 Apr; 178(4):315-325. PubMed ID: 34301405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the Biological Activity of the Glucan Phosphatase Laforin.
    Romá-Mateo C; Raththagala M; Gentry MS; Sanz P
    Methods Mol Biol; 2016; 1447():107-19. PubMed ID: 27514803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lafora disease offers a unique window into neuronal glycogen metabolism.
    Gentry MS; Guinovart JJ; Minassian BA; Roach PJ; Serratosa JM
    J Biol Chem; 2018 May; 293(19):7117-7125. PubMed ID: 29483193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.
    Irimia JM; Tagliabracci VS; Meyer CM; Segvich DM; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2015 Sep; 290(37):22686-98. PubMed ID: 26216881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Aguado C; García-Giménez JL; Knecht E; Sanz P; Pallardó FV
    Free Radic Biol Med; 2015 Nov; 88(Pt A):30-41. PubMed ID: 25680286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lafora Disease: A Ubiquitination-Related Pathology.
    García-Gimeno MA; Knecht E; Sanz P
    Cells; 2018 Jul; 7(8):. PubMed ID: 30050012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease.
    Perez-Jimenez E; Viana R; Muñoz-Ballester C; Vendrell-Tornero C; Moll-Diaz R; Garcia-Gimeno MA; Sanz P
    Glia; 2021 May; 69(5):1170-1183. PubMed ID: 33368637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein degradation and quality control in cells from laforin and malin knockout mice.
    Garyali P; Segvich DM; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2014 Jul; 289(30):20606-14. PubMed ID: 24914213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.